Illness	Number of cases
Malignant neoplasm of prostate (C61)	303
Cystitis (N30.0)	275
Calculus of kidney and ureter - Calculus of kidney (N20.0)	240
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	233
Hyperplasia of prostate (N40)	179
Unspecified haematuria (R31)	140
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	123
Calculus of kidney and ureter - Calculus of ureter (N20.1)	118
Malignant neoplasm of bladder - Malignant neoplasm of ureteric orifice (C67.6)	113
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	105

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.202
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	1.156
(5-98k.0)	1.148
Computer-assisted analysis of the images with 3D-analysis (3-990)	988
Insertion, exchange or removal of a ureteral stent (8-137.10)	703
Insertion, exchange or removal of a ureteral stent (8-137.00)	545
Computed tomography (CT) of the abdomen without contrast medium (3-207)	485
Computed tomography of the abdomen with contrast medium (3-225)	394
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	361
(8-137.20)	355

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ30

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
64	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
41	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
31	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities	Teilnahme an Hauptvorlesungen, fakultatives Lehrangebot Chirurgie, Gefäßchirurgie an der Charité
Participation in multi-centre Phase I/II studies

Training

No.	Training in other healing professions	Comment
HB18	Emergency paramedics (m/f) (training period 3 years)	Praxiseinrichtung
HB21	Geriatric nurse (m/f)	Praxiseinrichtung
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB17	Auxiliary nurse (m/f)	Pflegefachassistenten/-innen
HB15	Anaesthesia technical assistant (m/f)	Praxiseinrichtung ab 04/2025
HB07	Surgical technical assistant (m/f)	Praxiseinrichtung